ADA helped a global biotechnology company unify geographically disparate data and create controlled access to help researchers in their decision making processes

The customer is a leading biotechnology company focused on inventing, developing, and commercialising life-transforming medicines for people with serious diseases. Data plays a critical role across the organisation, enabling business intelligence, analytics teams, and researchers to perform accurate analyses, generate meaningful insights, and support informed decision-making.

The customer faced several challenges with its existing data landscape. Data was stored in silos across multiple geographies, making it difficult for business users to locate the information needed for their use cases. In addition, data existed in a wide range of formats and levels of complexity, creating further barriers to accessibility and analysis. The absence of robust data access governance also meant that research data lacked appropriate controls, increasing the risk of unrestricted access and limiting effective data management.

ADA built an end-to-end data pipeline to consolidate the disparate data sources and data formats into a single standardized data model. The data pipeline was augmented with data quality checks and tests to enforce rigorous data quality standards. Finally, we deployed a data governance tool to enable fine grained access controls across the business units.